Articles published by AmbioPharm

AmbioPharm Appoints Industry Veteran Brian Gregg as CEO

October 02, 2023

From AmbioPharm

Via Business Wire

AmbioPharm Provides an Update on South Carolina Headquarters Expansion

May 17, 2023

From AmbioPharm

Via Business Wire

AmbioPharm To Utilize YMC Twin-Column Chromatography in Large Scale Peptide Production

March 28, 2023

From AmbioPharm

Via Business Wire

AmbioPharm to Host a Sustainable Peptide Manufacturing Workshop at Biologics 2023

March 22, 2023

From AmbioPharm

Via Business Wire

Ariceum Therapeutics and AmbioPharm Enter Strategic Manufacturing and Supply Partnership

October 27, 2022

From AmbioPharm

Via Business Wire

OKYO Pharma Plans Q4 2022 IND Filing of OK-101 to treat Dry Eye Disease with Subsequent Phase 2 Initiation Alongside Peptide Manufacturing Partner, AmbioPharm

August 30, 2022

From AmbioPharm

Via Business Wire

Tickers OKYO

Amytrx Therapeutics Partners With AmbioPharm to Expand the Potential of Its Breakthrough Leukocyte-Targeting Anti-Inflammatory Human Peptides

July 26, 2022

From AmbioPharm

Via Business Wire

AmbioPharm Supports ONL Therapeutics with Peptide Manufacturing to Prepare for IND Application for Phase 2 Study

July 12, 2022

From AmbioPharm

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.